BLOG

Minnesota’s New Prescription Drug Price Transparency Reporting: What You Need to Know

Minnesota’s New Prescription Drug Price Transparency Reporting: What You Need to Know

Nov 6, 2023

Minnesota's New Prescription Drug Price Transparency Reporting: What You Need to Know | by: Sumeet Singh, Founder & Chairman | Article Posted: November 6, 2023 | In recent years, the transparency surrounding prescription drug pricing has become a focal point for...

Federal Regulation

DEA Reportedly Set to Revise SORS Guidelines and (Hopefully) Clarify the Meaning of “Suspicious”

<img decoding="async" src="https://pharma.solutions/wp-content/uploads/2022/02/blog-image-1080x675.jpg" alt="DEA Reportedly Set to Revise SORS Guidelines and (Hopefully) Clarify the Meaning of “Suspicious”" class="" width="1080" height="675" srcset="https://pharma.solutions/wp-content/uploads/2022/02/blog-image-980x539.jpg 980w, https://pharma.solutions/wp-content/uploads/2022/02/blog-image-480x264.jpg 480w" sizes="(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1080px, 100vw" />

DEA Reportedly Set to Revise SORS Guidelines and (Hopefully) Clarify the Meaning of “Suspicious”

Jan 18, 2018

DEA Reportedly Set to Revise SORS Guidelines and (Hopefully) Clarify the Meaning of “Suspicious” As the opioid crisis continues to grow and further...

DEA Reportedly Set to Revise SORS Guidelines and (Hopefully) Clarify the Meaning of “Suspicious”

<img decoding="async" src="https://pharma.solutions/wp-content/uploads/2022/02/blog-image-1080x675.jpg" alt="DEA Reportedly Set to Revise SORS Guidelines and (Hopefully) Clarify the Meaning of “Suspicious”" class="" width="1080" height="675" srcset="https://pharma.solutions/wp-content/uploads/2022/02/blog-image-980x539.jpg 980w, https://pharma.solutions/wp-content/uploads/2022/02/blog-image-480x264.jpg 480w" sizes="(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1080px, 100vw" />

Biggest Industry Players Face Pressure from Public and the DEA on Suspicious Order Monitoring

Jan 9, 2018

Biggest Industry Players Face Pressure from Public and the DEA on Suspicious Order Monitoring The Opioid Epidemic has been a devastating trend in...

FDA Authorizes Florida’s Drug Importation Program

<img decoding="async" src="https://pharma.solutions/wp-content/uploads/2024/01/Blog-Featured-Images-1600x880-3-100x55.png" alt="FDA Authorizes Florida’s Drug Importation Program" itemprop="image" class="left" />

FDA Authorizes Florida’s Drug Importation Program

January 9, 2024January 10, 2024

FDA Warning on Xylazine: Mitigating Human Risk

<img decoding="async" src="https://pharma.solutions/wp-content/uploads/2023/11/Blog-Featured-Images-1600x880-25-100x55.png" alt="FDA Warning on Xylazine: Mitigating Human Risk" itemprop="image" class="left" />

FDA Warning on Xylazine: Mitigating Human Risk

November 6, 2023November 6, 2023

Minnesota’s New Prescription Drug Price Transparency Reporting: What You Need to Know

<img decoding="async" src="https://pharma.solutions/wp-content/uploads/2023/11/Blog-Featured-Images-1600x880-24-100x55.png" alt="Minnesota’s New Prescription Drug Price Transparency Reporting: What You Need to Know " itemprop="image" class="left" />

Minnesota’s New Prescription Drug Price Transparency Reporting: What You Need to Know

November 6, 2023

FDA Authorizes Florida’s Drug Importation Program

<img decoding="async" src="https://pharma.solutions/wp-content/uploads/2024/01/Blog-Featured-Images-1600x880-3-100x55.png" alt="FDA Authorizes Florida’s Drug Importation Program" itemprop="image" class="left" />

FDA Authorizes Florida’s Drug Importation Program

January 9, 2024January 10, 2024

FDA Warning on Xylazine: Mitigating Human Risk

<img decoding="async" src="https://pharma.solutions/wp-content/uploads/2023/11/Blog-Featured-Images-1600x880-25-100x55.png" alt="FDA Warning on Xylazine: Mitigating Human Risk" itemprop="image" class="left" />

FDA Warning on Xylazine: Mitigating Human Risk

November 6, 2023November 6, 2023

Minnesota’s New Prescription Drug Price Transparency Reporting: What You Need to Know

<img decoding="async" src="https://pharma.solutions/wp-content/uploads/2023/11/Blog-Featured-Images-1600x880-24-100x55.png" alt="Minnesota’s New Prescription Drug Price Transparency Reporting: What You Need to Know " itemprop="image" class="left" />

Minnesota’s New Prescription Drug Price Transparency Reporting: What You Need to Know

November 6, 2023